Octagon Capital Advisors LP Iveric Bio, Inc. Transaction History

Octagon Capital Advisors LP

  • $414 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$17.24 - $23.95 $22 Million - $30.6 Million
1,278,000 New
1,278,000 $27.4 Million
Q4 2021

Feb 14, 2022
SELL
$13.83 - $18.78 $3.83 Million - $5.2 Million
-277,057 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$7.07 - $17.5 $2.85 Million - $7.05 Million
-402,979 Reduced 59.26%
277,057 $4.5 Million
Q4 2020

Feb 16, 2021
BUY
$5.65 - $7.66 $3.84 Million - $5.21 Million
680,036 New
680,036 $4.7 Million

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email